Rtw Investments, LP Protagonist Therapeutics, Inc Transaction History

Rtw Investments, LP

  • $5.99 Billion
  • Q2 2024

A detailed history of Rtw Investments, LP transactions in Protagonist Therapeutics, Inc stock. As of the latest transaction made, Rtw Investments, LP holds 5,286,404 shares of PTGX stock, worth $242 Million. This represents 3.06% of its overall portfolio holdings.

Number of Shares
5,286,404
Previous 5,315,514 0.55%
Holding current value
$242 Million
Previous $154 Million 19.12%
% of portfolio
3.06%
Previous 2.47%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$24.66 - $34.8 $717,852 - $1.01 Million
-29,110 Reduced 0.55%
5,286,404 $183 Million
Q4 2023

Feb 14, 2024
SELL
$14.05 - $23.44 $1.41 Million - $2.34 Million
-100,000 Reduced 1.85%
5,315,514 $122 Million
Q2 2023

Aug 14, 2023
BUY
$18.02 - $29.36 $14.7 Million - $23.9 Million
814,715 Added 17.71%
5,415,514 $150 Million
Q1 2023

May 15, 2023
BUY
$10.78 - $25.38 $10.9 Million - $25.6 Million
1,008,813 Added 28.09%
4,600,799 $106 Million
Q4 2022

Feb 14, 2023
SELL
$7.36 - $11.17 $4.3 Million - $6.53 Million
-584,851 Reduced 14.0%
3,591,986 $39.2 Million
Q3 2022

Nov 14, 2022
SELL
$7.86 - $11.71 $4.85 Million - $7.23 Million
-617,662 Reduced 12.88%
4,176,837 $35.2 Million
Q1 2022

May 16, 2022
BUY
$23.34 - $36.08 $51.2 Million - $79.2 Million
2,194,677 Added 84.42%
4,794,499 $114 Million
Q4 2021

Feb 14, 2022
BUY
$17.63 - $37.1 $14.9 Million - $31.4 Million
846,127 Added 48.25%
2,599,822 $88.9 Million
Q3 2021

Nov 15, 2021
SELL
$12.95 - $49.69 $22.7 Million - $87.1 Million
-1,753,695 Reduced 50.0%
1,753,695 $31.1 Million
Q1 2021

May 14, 2021
SELL
$19.02 - $31.15 $2.71 Million - $4.44 Million
-142,679 Reduced 3.91%
3,507,390 $90.8 Million
Q4 2020

Feb 16, 2021
BUY
$18.49 - $25.13 $4.46 Million - $6.06 Million
241,108 Added 7.07%
3,650,069 $73.6 Million
Q3 2020

Nov 16, 2020
BUY
$15.19 - $22.4 $391,188 - $576,867
25,753 Added 0.76%
3,408,961 $66.6 Million
Q2 2020

Aug 14, 2020
BUY
$6.19 - $18.84 $4.47 Million - $13.6 Million
722,816 Added 27.17%
3,383,208 $59.7 Million
Q1 2020

May 15, 2020
BUY
$5.4 - $9.22 $1.08 Million - $1.85 Million
200,404 Added 8.15%
2,660,392 $18.8 Million
Q4 2019

Feb 14, 2020
BUY
$4.69 - $13.45 $7.96 Million - $22.8 Million
1,697,705 Added 222.71%
2,459,988 $17.3 Million
Q3 2019

Nov 14, 2019
BUY
$9.41 - $16.56 $7.17 Million - $12.6 Million
762,283 New
762,283 $9.16 Million

Others Institutions Holding PTGX

# of Institutions
212
Shares Held
59.1M
Call Options Held
19K
Put Options Held
107K
View Full List

About Protagonist Therapeutics, Inc

PTGX Quotes by TradingView
  • Ticker PTGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,084,100
  • Market Cap $2.25B
  • Description
  • Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...
More about PTGX
Track This Portfolio

Track Rtw Investments, LP Portfolio

Follow Rtw Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rtw Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Rtw Investments, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email